Innovate Alabama Opens Second Round Of Small Business Grants

The Alabama Innovation Corporation (Innovate Alabama) recently opened applications for Phase I, round two of the Innovate Alabama Supplemental Grant Program. Through February 17, Alabama-based recipients of Phase I and Phase II Federal Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) grants are eligible to apply for up to $250,000 in supplemental funding. Eligible applicants must have had an active Phase I or II SBIR or STTR grant on July 1, 2021, or later. Phase I recipients are eligible to apply for 50% of their award up to $100,000, and Phase II recipients are eligible to apply for 50% of their award up to $250,000. Innovate Alabama launched the statewide program in July 2022, awarding more than $4.5 million in supplemental funding to 30 grant recipients in six Alabama cities to support the growth of their small businesses (BBN #102). Most recently, Mobile-based Clarity, aka Sure Med Compliance, was among 30 winners awarded up to $250,000 in the first round of supplemental funding.

Read More

Big Brothers Big Sisters Event Coming To Crown Hall

Big Brothers Big Sisters Event Coming To Crown Hall

HFHSWA Kicks Off Women Build

HFHSWA Kicks Off Women Build

Two Hand Arendall Harrison Sale Lawyers Named Lawyers Of The Year

Two Hand Arendall Harrison Sale Lawyers Named Lawyers Of The Year

USA Health Adds Trauma/Critical Care Surgeon

USA Health Adds Trauma/Critical Care Surgeon

Franklin Primary Health Center Hosting Wellness Event

Franklin Primary Health Center Hosting Wellness Event

Cardiology Associates Adds Apex Cardiovascular Imaging System

Cardiology Associates Adds Apex Cardiovascular Imaging System

Mobile Relaunches Public Transit

Mobile Relaunches Public Transit

CSU Adds Programs

CSU Adds Programs

UM, CACC Partner For Education Transfers

UM, CACC Partner For Education Transfers

Subscribe to our weekly newsletter

Sign up here for free to get Bay Business News email newsletter every Friday.

By subscribing, you agree to our User Agreement and Privacy Policy & Cookie Statement.

Something went wrong. Please check your entries and try again.